- In February 2023, Abbott acquired Cardiovascular Systems Inc. (CSI), strengthening its position in the market with advanced diagnostic products. This acquisition provided Abbott with access to CSI's cutting-edge atherectomy devices, which are highly effective in treating vascular diseases. The move enhanced Abbott's portfolio, giving it a competitive advantage in the cardiovascular space
- In 2023, Siemens unveiled its Somatom Pro.Pulse at RSNA, offering high-resolution cardiac imaging at an affordable cost, specifically designed for patients with elevated heart rates. Likewise, Canon introduced the Aquilion One Insight Edition, which provides complete heart scans in a single rotation, significantly reducing imaging time and enhancing efficiency. These innovations highlight advancements in cardiac imaging, improving both affordability and patient care
- In September 2021, AstraZeneca India collaborated with Bengaluru-based startup Tricog to launch Project Heart Beat. This initiative aimed to improve heart disease diagnosis and treatment using advanced technology. The partnership focused on leveraging Tricog’s AI-driven solutions to enhance cardiovascular care across India
- In April 2021, Roche introduced a series of five new applications for two key cardiac biomarkers—highly sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide (NT-proBNP) tests—using its Elecsys® technology. This expansion aimed to enhance the diagnostic capabilities for heart-related conditions. The new tests improve early detection and monitoring, offering healthcare providers advanced tools for cardiovascular disease management
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Electron Beam Computed Tomography, Nuclear Heart Scan, Echocardiogram (ECG), Cardiac Catheterization, Coronary Arteriography, Angiocardiography, and Others), Indication (Congenital Heart Diseases, Coronary Artery Blockage, Defects or Injuries to the Heart’s Four Primary Valves, Blood Clots within the Heart, Tumours in or on the Heart, and Others), End User (Hospitals and Clinics, Diagnostic Centres, Cardiac Care Centres, Ambulatory Centres and Home Care, Academic Institutes, and Others) – Industry Trends and Forecast to 2032
.
The Global Heart Scan Market size was valued at USD 15.97 USD Billion in 2024.
The Global Heart Scan Market is projected to grow at a CAGR of 6.54% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
